An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel
(E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month
to Less Than 4 Years of Age With Epilepsy
For 1 month to less than 4 years with any seizure type continuing to have seizures
while using 1-4 seizure medications
A MULTICENTER, OPEN-LABEL, RANDOMIZED, ACTIVE COMPARATOR STUDY TO EVALUATE THE EFFICACY,
SAFETY, AND PHARMACOKINETICS OF LACOSAMIDE IN NEONATES WITH REPEATED ELECTROENCEPHALOGRAPHIC
NEONATAL SEIZURES
For newborns up to 28 days of age with seizures
A Randomized, Dose-finding and Confirmatory, Double-blind, Placebo-controlled, Parallel-group
Multicenter Study with a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate
the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients
2 to 25 Years of Age with Childhood Absence Epilepsy or Juvenile Absence Epilepsy
For 2 to 25 years have childhood or juvenile absence seizures not currently treated
with other seizure medications
